Welcome to our dedicated page for Caring Brands SEC filings (Ticker: CABR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Caring Brands, Inc. filings document the company's securities registration, capital structure, governance changes, and material events as a Nasdaq-listed wellness consumer products issuer. Its S-1 registration materials describe common stock offerings, business disclosures, risk factors, financial statements, and the company's OTC and cosmetic product focus.
Recent 8-K filings cover Nasdaq continued-listing compliance, amendments to shareholder-meeting quorum requirements, executive finance-function changes, and financing transactions involving Series A Convertible Preferred Stock, common warrants, and insider share redemptions. Other event disclosures record patent-related updates for the Hair Enzyme Booster product and related intellectual property matters.
Caring Brands, Inc. entered into a private investment in public equity on July 10, 2026, selling 443.2133 shares of Series A Convertible Preferred Stock with a stated value of $1,000 per share at $950 per share and issuing 1,052,632 common stock warrants at a $0.40 exercise price.
The transaction generated $400,000 in gross proceeds; $150,000 will be used to retire 150,000 common shares from BK Investments LLC, with the remainder for general corporate and working capital purposes. An amendment increased authorized Series A Preferred shares to 4,500 and set an 8% dividend, while warrant exercises and conversions are limited by a 4.99% beneficial ownership cap and a 19.99% issuance cap without shareholder approval.
Caring Brands, Inc. held a Special Meeting of Stockholders on July 9, 2026. As of the May 14, 2026 record date, there were 9,091,506 shares of common stock outstanding and entitled to vote. Holders of 5,617,697 shares, representing approximately 61.79% of eligible shares, were present in person or by proxy, constituting a quorum.
Stockholders approved three proposals. The Additional Investment Right Proposal received 4,457,375 votes for, 155,999 against and 1,000 abstentions, with 1,003,323 broker non-votes. The Share Issuance Proposal received 4,456,776 for, 156,598 against and 1,000 abstentions, with 1,003,323 broker non-votes. The Increase in the Number of Authorized Shares of Common Stock Proposal received 5,118,645 for, 498,052 against and 1,000 abstentions, with no broker non-votes. No other substantive matters were voted on.
Caring Brands Inc. entered into an expanded multi-territory licensing agreement with SanPellegrino Cosmetics Private Limited for its Photocil and Hair Enzyme Booster products. The revised agreement, effective May 21, 2026, introduces a five-year initial term with automatic annual renewal.
The deal broadens SCPL’s licensed territory beyond India to include multiple LATAM countries, Russia, Australia and New Zealand, leveraging existing sublicense partnerships with Eris Lifesciences and Glenmark Pharmaceuticals. Caring Brands highlights that this expansion supports its strategy to grow revenue from patented, clinically validated skin and hair-growth products across high-growth international markets.
Caring Brands, Inc. filed a current report to correct an administrative error in its proxy materials. The company’s Definitive Proxy Statement for its annual meeting had incorrectly listed May 12, 2026 as the record date. The correct record date for determining stockholders entitled to receive notice of, and vote at, the annual meeting is May 14, 2026.
All other information in the original proxy statement remains unchanged, and only stockholders of record as of May 14, 2026 will be eligible to participate in the meeting. The company plans to file a revised definitive proxy statement reflecting this corrected date.
Caring Brands, Inc. has called a July 9, 2026 special meeting to approve several capital-structure changes tied to a March 19, 2026 financing. The company agreed to sell up to $3,600,000 of Series A Convertible Preferred Stock and five-year Warrants to institutional and accredited investors.
Shareholders are asked to approve an Additional Investment Right allowing investors to buy more Series A and Warrants, authorize issuing common shares on conversion and exercise above 19.99% of prior outstanding stock, increase authorized common from 100,000,000 to 500,000,000 shares, and permit adjournments to solicit more proxies.
Caring Brands, Inc. is asking shareholders to approve four proposals at a Special Meeting: (1) an "Additional Investment Right" under a March 19, 2026 Securities Purchase Agreement, (2) issuance of conversion/exercise shares that may exceed 19.99% of outstanding common stock, (3) increase authorized common shares from 100,000,000 to 500,000,000, and (4) an adjournment authority to solicit further proxies.
The SPA contemplates up to $3,600,000 of Series A Convertible Preferred Stock and Warrants; the Series A designation covers 25,000 preferred shares, and the Warrants carry a $0.40 exercise price and a 5-year term. Shares outstanding were 9,091,506 as of the Record Date. Board recommends a vote FOR all proposals.
Caring Brands, Inc. reported a larger quarterly loss with no revenue as it continues early-stage development of its wellness products. For the three months ended March 31, 2026, the company generated no revenue and recorded a net loss of $2,008,476, compared with $538,770 a year earlier. Net loss attributable to common stockholders was $3,853,083, or $0.27 per share, reflecting significant accretion on redeemable preferred stock.
Operating expenses rose to $1,721,499, driven mainly by higher payroll, stock-based compensation, and professional fees tied to public company and capital markets activities. Interest expense of $286,989 was largely non-cash, linked to a convertible note that was fully converted into equity.
The company ended the quarter with cash and cash equivalents of $2,033,438 and total assets of $2,171,749. It completed a PIPE financing of Series A Convertible Redeemable Preferred Stock with approximately $3.6M stated value and repurchased 6,250,000 common shares for $3,075,000. Management believes current cash can fund operations for at least twelve months, but the filing highlights a going concern uncertainty, a Nasdaq stockholders’ equity deficiency notice, substantial accumulated deficit, and material weaknesses in internal controls.
Caring Brands, Inc. has filed a resale registration covering 18,947,370 shares of common stock, all to be offered from time to time by a selling stockholder. These consist of 9,473,685 shares issuable upon conversion of Series A Convertible Preferred Stock and 9,473,685 shares issuable upon exercise of common warrants, each at $0.40 per share.
The company will not receive proceeds from the resale, but could receive about $3.79 million in cash if all warrants are exercised. Caring Brands reports nominal revenues and net losses of $6.28 million for 2025 and $1.52 million for 2024, raising going-concern doubts, and recently received a Nasdaq notice for not meeting the $2.5 million stockholders’ equity requirement. As of the prospectus date, it has 8,941,506 shares outstanding and describes significant risks around liquidity, competition, regulation and product development.
Caring Brands, Inc. received a Nasdaq Staff Delisting Determination after falling out of compliance with Nasdaq Listing Rule 5550(b)(1), which requires at least $2.5 million in stockholders’ equity. The company’s latest Form 10-K reported stockholders’ equity of $2,091,324, triggering the notice.
Caring Brands has 45 days, until May 22, 2026, to submit a plan to regain compliance and could receive up to 180 days, until October 4, 2026, to demonstrate compliance if Nasdaq accepts the plan. The notice does not immediately affect trading, and the stock continues to trade on Nasdaq under the symbol CABR, but failure to regain compliance could lead to delisting.